TABLE 3.

Drug-susceptibility of major Gram-positive bacteria of LRTI patients from different wards (%).

Antibacterials	Staphylococcus aureus			Staphylococcus epidermidis			Streptococcus pneumoniae
	PW (n = 70)	ARD (n = 59)	RICU (n = 68)	PW (n = 59)	ARD (n = 8)	RICU (n = 11)	PW (n = 43)	ARD (n = 19)	RICU (n = 3)
Benzylpenicillin	15.71	3.39	0.00	25.42	0.00	0.00	79.07	78.95	33.33
Oxacillin	77.14	59.32	20.59	30.51	25.00	9.09	–	–
Gentamicin	92.86	61.02	44.12	89.83	100.00	72.73	–	–	–
Levofloxacin	100.00	40.68	29.41	86.44	50.00	63.63	97.67	89.47	66.67
Moxifloxacin	100.00	52.54	29.41	84.75	75.00	72.73	97.67	94.74	66.67
Erythromycin	24.29	23.72	8.82	23.73	0.00	18.18	0.00	0.00	0.00
Clindamycin	54.29	45.76	39.71	72.89	75.00	72.73	0.00	10.53	0.00
Linezolid	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Daptomycin	100.00	100.00	100.00	100.00	100.00	100.00	–	–	–
Teicoplanin	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Vancomycin	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Tigecycline	100.00	100.00	100.00	100.00	100.00	100.00	–	–	–
Rifampicin	100.00	74.57	80.88	96.61	100.00	90.90	100.00	100.00	100.00
Trimethoprim/Sulfamethoxazole	88.57	79.66	88.24	66.10	62.50	63.64	41.86	47.37	33.33

PW, pediatric ward; ARD, adult respiratory ward; RICU, respiratory intensive care unit.